- Home
- GPRO vs GNFT Comparison
GPRO vs GNFT Comparison
Compare GPRO & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- GNFT
- Stock Information
- Founded
- GPRO 2004
- GNFT 1999
- Country
- GPRO United States
- GNFT France
- Employees
- GPRO N/A
- GNFT N/A
- Industry
- GPRO Industrial Machinery/Components
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRO Consumer Discretionary
- GNFT Health Care
- Exchange
- GPRO Nasdaq
- GNFT Nasdaq
- Market Cap
- GPRO 193.5M
- GNFT 179.7M
- IPO Year
- GPRO 2014
- GNFT 2019
- Fundamental
- Price
- GPRO $1.05
- GNFT $3.91
- Analyst Decision
- GPRO Hold
- GNFT Strong Buy
- Analyst Count
- GPRO 1
- GNFT 1
- Target Price
- GPRO $1.50
- GNFT $13.00
- AVG Volume (30 Days)
- GPRO 1.6M
- GNFT 9.9K
- Earning Date
- GPRO 02-06-2025
- GNFT 09-19-2024
- Dividend Yield
- GPRO N/A
- GNFT N/A
- EPS Growth
- GPRO N/A
- GNFT N/A
- EPS
- GPRO N/A
- GNFT 0.47
- Revenue
- GPRO $896,011,000.00
- GNFT $86,225,222.00
- Revenue This Year
- GPRO N/A
- GNFT $145.20
- Revenue Next Year
- GPRO N/A
- GNFT N/A
- P/E Ratio
- GPRO N/A
- GNFT $7.89
- Revenue Growth
- GPRO N/A
- GNFT 175.45
- 52 Week Low
- GPRO $0.89
- GNFT $3.35
- 52 Week High
- GPRO $3.03
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- GPRO 48.92
- GNFT 54.95
- Support Level
- GPRO $0.89
- GNFT $3.68
- Resistance Level
- GPRO $1.04
- GNFT $3.96
- Average True Range (ATR)
- GPRO 0.05
- GNFT 0.13
- MACD
- GPRO -0.00
- GNFT 0.05
- Stochastic Oscillator
- GPRO 68.76
- GNFT 79.49
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts, drones and appliances. The company outsources a part of manufacturing to third parties in China. The company sells products across the world through its direct sales channel, which generates over half of total revenue, and indirectly through its distribution channel. The company has presence, including in the Americas, Europe, Middle East, Africa, and Asia-Pacific, with the Americas contributing over half of total revenue.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.